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Comment on ‘Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic
review and meta-analysis’
J H Park*,1, C S D Roxburgh1 and D C McMillan1
1Academic Unit of Surgery, School of Medicine, University of Glasgow, Glasgow, UK
Sir,
We read with interest the recent meta-analysis by Mei et al (2014). In this
study, Mei et al examined the prognostic value of the local inflammatory
infiltrate in colorectal cancer as measured by both the generalised
inflammatory infiltrate and by immunohistochemical analysis of T-lympho-
cytic subsets. The authors concluded that, in comparison with assessment of
T-cell subset density, semiquantitative assessment of the generalised
inflammatory infiltrate at the invasive margin, utilising the Jass score or
Klintrup–Ma¨kinen grade (Jass et al, 1987; Klintrup et al, 2005), was a more
robust prognostic marker of cancer-specific, overall and disease-recurrence-
free survival. Indeed, in patients undergoing resection for Stage I–III disease, a
high-density generalised inflammatory infiltrate was associated with an almost
60% increase in overall survival.
The present study mirrors recent results from both our group and others
(Vayrynen et al, 2013; Richards et al, 2014). In 365 patients undergoing
potentially curative resection for Stage I–III colorectal cancer, Klintrup–
Ma¨kinen grade strongly correlated with T-cell subtype density in the invasive
margin, tumour stroma and cancer cell nests (Richards et al, 2014).
Furthermore, on univariate analysis, a strong Klintrup–Ma¨kinen grade was
associated with improved cancer-specific survival (hazard ratio 0.54, 95%
confidence interval 0.43–0.68); indeed this was comparable if not superior to the
prognostic utility of measuring T-cell subtype density or the use of a composite
score, such as the Galon Immune Score. Similarly, in a cohort of 117 patients
with Stage I–IV colorectal cancer undergoing resection, Vayrynen et al (2013)
found that Klintrup–Ma¨kinen grade closely correlated with not only T-cell
density, but also macrophage, neutrophil and dendritic cell density at both the
invasive margin and within the intratumoural compartment. In addition,
Klintrup–Ma¨kinen score was associated with recurrence-free survival.
Therefore, taken together, these results are consistent with the concept that
increased density of an inflammatory cell infiltrate in the tumour
microenvironment represents a coordinated effective immune response and
that individual inflammatory cell types offer little additional prognostic
value. If this proves to be the case, then it may be that the conspicuous
inflammatory cell infiltrate, long recognised by investigators to be associated
with good outcome, is the normal immune response to a colorectal cancer and
that the abnormal response is a scarce or absent inflammatory cell infiltrate,
representing an uncoordinated immune response. The implications of such a
hypothesis are several and profound. First, the immune context in which an
inflammatory cell is found in the tumour microenvironment would become of
paramount importance. Second, it would move the focus of investigations
from the nature of the inflammatory cell infiltrate in those with a
conspicuous inflammatory cell infiltrate to those with a scarce or absent
inflammatory cell infiltrate (eg, see Mohammed et al, 2012; Richards et al,
2012). Third, it would become a pre-requisite of all investigations that
the density of the tumour inflammatory cell infiltrate in the tumour
microenvironment is defined.
With this in mind we have recently validated an automated, computer-
based scoring method with similar prognostic value to the Klintrup–Ma¨kinen
grade (Forrest et al, 2014). It is hoped that introduction of such a tool will
facilitate the incorporation of such an assessment of the generalised
inflammatory cell infiltrate into routine clinical practice and provide a solid
platform for the further investigation of the importance of inflammatory cell
infiltrate (absent–scarce/conspicuous) in determining outcome in patients
with colorectal cancer.
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Response to comment on ‘Tumour-infiltrating inflammation and prognosis in colorectal cancer:
systematic review and meta-analysis’
Z Mei1, Y Liu1, C Liu1 and L Cui*,1
1Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of
China
Sir,
We are most grateful to Professor Park, McMillan and Roxburgh (2014) for
their interest and valuable comments on our manuscript titled ‘Tumour-
infiltrating inflammation and prognosis in colorectal cancer: systematic review
and meta-analysis’ (Mei et al, 2014). They cited several recently published
studies with consistent results, pointing out some other important relation-
ships among inflammatory cell infiltrate, the tumour microenvironment
and immune response in colorectal cancer (CRC), which were not
discussed in detail in our original publication because of the length of the
publication. Therefore, some major concerns, such as the following, must be
addressed.
First, the analytical methods used in our publication for the generalised
tumour inflammatory infiltrate were relatively standardised ones and included
the Jass classification, the Klintrup—Makinen (K–M) criteria and Crohn’s-like
reaction criteria. The pooled hazard ratios and 95% CIs for overall survival,
cancer-specific survival and disease/recurrence-free survival in a subset of
highly generalised tumour inflammatory infiltrate were o1, indicating a
robust survival marker for CRC. However, conflicting results (with HRs and
95% CI across 1) were noted among individual studies as heterogeneity
originated from local inflammatory reaction grading systems, patient
characteristics, follow-up schemes and some other factors, which was
especially evident among individual T-cell subtypes. More detailed
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